InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Hagan Joseph P, 董事长兼首席执行官. Officer active across 4 companies, notably Regulus Therapeutics Inc.. In total, 12 reports have been published. Split: 2 buys · 4 sells. Total volume traded: €235k. Activity tracked since 17 May 2021. The latest transaction was filed on 30 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hagan Joseph P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
571,558 股Common StockSEC:0000950170-25-091015:0
50,000 股@ US$1.08529.6% 占其流量Common StockSEC:0000950170-25-011853:0
标准退出：2025年4月30日 (T+90)
115,290 股@ US$1.263226.2% 占其流量Common StockSEC:0000950170-25-005883:0
218,750 股@ US$1.3653.1% 占其流量Common StockSEC:0000950170-25-004274:0
14,580 股@ US$1.19062.9% 占其流量Common StockSEC:0001209191-24-001873:0
30,000 股0Common StockSEC:0001209191-24-001778:0
8,733 股Common StockSEC:0001600620-23-000021:0
272 股@ US$10.580.7% 占其流量Common StockSEC:0001600620-23-000021:1
100,000 股@ US$0.21523.7% 占其流量Common StockSEC:0001209191-22-005061:0
标准退出：2022年4月26日 (T+90)
40,000 股@ US$5.0898.5% 占其流量Common StockSEC:0001628280-22-000182:0
15,000 股0Common StockSEC:0001567619-21-012083:0
4,186 股@ US$0.890.6% 占其流量Common StockSEC:0001209191-21-033297:0
12 条申报中的 12 条
About Hagan Joseph P
Joseph P. Hagan serves as President & CEO and Board Member at Regulus Therapeutics Inc. and Zosano Pharma Corp. In this role, he oversees the operations and strategy of both companies. His expertise in the biopharmaceutical sector allows him to contribute to innovation and growth.
